Insulin-Production Restoration
Restore the body’s own ability to make insulin
The goal is to restore the body’s own insulin production — ending dependence on lifelong injections in diabetes. Behind the biology is a human being who would feel the difference in their daily life — that is the whole point.
The pancreas makes both the insulin that controls blood sugar and the enzymes that digest food. When its insulin-producing cells are lost, diabetes follows and means lifelong injections; when its digestive function fails, nutrition suffers. Restoring the body’s own insulin and digestive capacity would change diabetes and pancreatic disease at the root. For someone with diabetes, restoring the body’s own insulin is the difference between managing a disease and being free of it.
We are building the capability to restore insulin production: replacing the insulin-making cells, protecting them from the immune system, and regenerating them in the body. The aim is a clear path from what already works in the clinic today to the regenerative science advancing toward tomorrow — honestly staged at every step.
How it works
Stem-cell-derived islets Demonstrated in research
Insulin-producing cells made from stem cells have restored insulin production in early human trials.
Protecting new cells Frontier
Shielding transplanted islets from immune attack — without lifelong immune suppression — is a key frontier.
Regenerating islets in place Frontier
Coaxing the pancreas to regrow its own insulin cells is early-stage laboratory science.
Pairing repair with rehabilitation Clinical
Combining tissue or cell repair with intensive, targeted rehabilitation drives the fullest functional recovery — established in practice.
Cited as evidence the capability is real — not as partners or endorsers.
Government & programs
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, NIH) · NIH diabetes programs. These public programs fund the foundational research that shows the capability is real.
Universities & institutes
Academic diabetes, islet-biology, and pancreas-regeneration research centers. Academic laboratories carry that science from discovery toward the clinic.
Enabling science base
beta-cell & islet biology · stem-cell-derived islets · exocrine biology · immune tolerance. — the established disciplines this capability is built upon.
The technologies: stem-cell-derived insulin-producing cells, islet replacement and protection, exocrine-restoration approaches, and immune-tolerance therapies that protect new cells.
Stem-cell islets Demonstrated
Lab-made islets restore insulin in early trials.
Immune protection Frontier
Protecting new cells without suppression is early-stage.
In-place regeneration Frontier
Regrowing islets in the body is early-stage.
Clinical translation underway Clinical trials
Several restorative approaches have moved from the lab into human trials — the bridge from demonstrated biology to everyday care.
The honest challenges: making insulin-producing cells is demonstrated; protecting them durably from the immune system and scaling the approach are the central frontiers. Getting new cells and tissue to survive, connect, and function durably in a living person — not just in a dish or an animal — is the central work, and it is exactly where the most careful, best-funded research is now aimed. We show where each piece stands, so the promise is never mistaken for the proof.
The future, fully built
A person with diabetes has their own insulin production restored — insulin-making cells replaced and protected — so daily injections give way to a body that regulates itself. — and the honest staging on this page shows just how much of that future is already real, and how much is still being built.
The proof, for this capability
Cited as evidence the capability is real, not as partners or endorsers.
Stem-cell islets
Restore insulin in early human trials. Stage: Demonstrated.
Immune protection
Durable protection without suppression is early-stage. Stage: Frontier.
In-place regeneration
Regrowing islets is early-stage. Stage: Frontier.
Honest framing
Real organizations are cited as evidence the capability is real — not as partners or endorsers. Stem-cell islets are demonstrated in early trials; durable, suppression-free protection in people is frontier.
Where it stands
Each line above is tagged for its stage — demonstrated, clinical, or frontier — so the page shows exactly how far the real science has come, and how far is left.
Help build this future
Every signature grows the movement to make insulin-production restoration real — and free at the point of need.